RENOL POLYCHEM LIMITED Fair Value
RNPL · Chemicals · Current price ₹77.25
| Method | Fair value | Status |
|---|---|---|
| Residual income | ₹97 | 14% ROE fading to 13% over ~3 yrs, on ₹95 book |
| Relative P/E | ₹289 | EPS × 39.9 peer-median P/E |
| Graham floor | ₹124 | Conservative floor: √(22.5 × EPS × book value/share) |
| Analyst target | — | No analyst coverage |
Is RENOL POLYCHEM LIMITED undervalued?
DocStoX estimates the fair value of RENOL POLYCHEM LIMITED at ₹153 per share, versus the current market price of ₹77. That puts the stock about +97.5% below our fair-value estimate, which we read as "Buy". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹97), Relative P/E (₹289), Graham floor (₹124). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹97 (bear) to ₹153 (base) to ₹289 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
More on RENOL POLYCHEM LIMITED
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.